Attached files
file | filename |
---|---|
EX-16.1 - Hydrogen Future Corp | v208083_ex16-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): January 10, 2011
A5
LABORATORIES INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
333-138927
|
20-5277531
|
(State
or other jurisdiction of
|
(Commission
File Number)
|
(IRS
Employer
|
incorporation)
|
Identification
No.)
|
10300
Chemin de la Cote-De-Liesse
Lachine,
Quebec H8T 1A3
|
(Address
of principal executive offices)
|
(514)
420-0333
Registrant’s
telephone number, including area code
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e
-4(c))
(a)
Resignation of Independent Registered Public Accounting Firm
On
January 10, 2011, the board of directors of A5 Laboratories Inc. (the “Company”)
accepted the resignation of Saturna Group Chartered Accountants, LLP
(“Saturna”), as the Company’s independent registered public accounting
firm.
Saturna
never audited the Company’s financial statements and did not review any interim
reports. During the period of retainment, there were no disagreements with
Saturna on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure.
The
Company has provided a copy of the above disclosures to Saturna and requested
Saturna to provide it with a letter addressed to the U.S. Securities and
Exchange Commission stating whether or not Saturna agrees with the above
disclosures. A copy of Saturna’s letter, dated January 13, 2011, confirming its
agreement with the disclosures in this Item 4.01 is attached as
Exhibit 16.1 to this Form 8-K.
(b)
New Independent Registered Public Accounting Firm
On January
10, 2011, the board of directors of the Company approved the engagement of
Berman & Co., P.A., Certified Public Accountants, Boca Raton, Florida
(“Berman”), as the Company’s new independent registered public accounting
firm.
During
the recent fiscal year ended September 30, 2010, and the subsequent interim
period prior to the engagement of Berman, the Company has not consulted Berman
regarding (i) the application of accounting principles to any specified
transaction, either completed or proposed, (ii) the type of audit opinion
that might be rendered on the Company’s financial statements, or (iii) any
matter that was either the subject of a disagreement (as defined in
Item 304(a)(1)(v)) or a reportable event (as defined in
Item 304(a)(1)(v)).
Item
9.01 Financial
Statements and Exhibits.
(d)
Exhibits
Exhibit
No.
|
Description
|
16.1
|
Letter
of Saturna Group Chartered Accountants, LLP, dated January 13,
2011
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date:
January 13, 2011
A5
LABORATORIES INC.
|
|
/s/ Richard Azani
|
|
Richard
Azani
|
|
Chief
Executive Officer
|